---
figid: PMC9410525__jcm-11-04643-g001
figtitle: 'Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical
  Approaches'
organisms:
- Nicotiana tabacum
- Embryophyta
- herbal medicine
- Panax ginseng
- Vitis vinifera
- Curcuma longa
- Camellia sinensis
- Ginkgo biloba
- Cannabis sativa
- Nigella sativa
- Crocus sativus
- Gastrodia elata
- Ruta graveolens
- Pulsatilla chinensis
- Oenothera biennis
- Boswellia papyrifera
- Mus musculus
- Rattus norvegicus
- Gallus gallus
- Acipenser ruthenus x Huso huso
- Homo sapiens
pmcid: PMC9410525
filename: jcm-11-04643-g001.jpg
figlink: /pmc/articles/PMC9410525/figure/jcm-11-04643-f001/
number: F1
caption: 'The MEK/ERK pathway represents the hub that connects many pathogenic factors
  involved in the onset of multiple sclerosis: inflammation, angiogenesis, and neurodegeneration.
  VEGF, via interaction with its receptor VEGFR, is the key protein that activates
  angiogenesis in response to inflammatory stimuli and is known to be neuroprotective.
  VEGF activates the downstream MEK/ERK pathway and is the main target of the current
  anti-angiogenic therapies. Moreover, ERK can be also activated in other ways, for
  example in microglial cells, thus contributing to inflammation and oligodendrocytes’
  alterations.'
papertitle: 'Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical
  Approaches.'
reftext: Maria Teresa Gentile, et al. J Clin Med. 2022 Aug;11(16):4643.
year: '2022'
doi: 10.3390/jcm11164643
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: MDPI
keywords: multiple sclerosis | angiogenesis | neuroprotection
automl_pathway: 0.951912
figid_alias: PMC9410525__F1
figtype: Figure
organisms_ner:
- Gallus gallus
- Rattus norvegicus
redirect_from: /figures/PMC9410525__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9410525__jcm-11-04643-g001.html
  '@type': Dataset
  description: 'The MEK/ERK pathway represents the hub that connects many pathogenic
    factors involved in the onset of multiple sclerosis: inflammation, angiogenesis,
    and neurodegeneration. VEGF, via interaction with its receptor VEGFR, is the key
    protein that activates angiogenesis in response to inflammatory stimuli and is
    known to be neuroprotective. VEGF activates the downstream MEK/ERK pathway and
    is the main target of the current anti-angiogenic therapies. Moreover, ERK can
    be also activated in other ways, for example in microglial cells, thus contributing
    to inflammation and oligodendrocytes’ alterations.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LITAF
  - IFNG
  - IFNA3
  - IL17A
  - IL22
  - IL2
  - VEGFA
  - Tnf
  - Ifng
  - Il17a
  - Il22
  - Il2
  - Vegfa
  - Mapk3
  - Mapk1
---
